Publications

Evaluation of the benefits and risks of introducing Ebola community care centers, Sierra Leone.

Abstract

In some parts of western Africa, Ebola treatment centers (ETCs) have reached capacity. Unless capacity is rapidly scaled up, the chance to avoid a generalized Ebola epidemic will soon diminish.

Kucharski AJ Camacho A Checchi F Waldman R Grais RF Cabrol JC Briand S Baguelin M Flasche S Funk S Edmunds WJ
Emerging infectious diseases 2015 Mar ; 21(3); 393-9. doi: 10.3201/eid2103.141892. Epub 2015 10 09

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage.

Abstract

Mycobacterium tuberculosis strains of the Beijing lineage are globally distributed and are associated with the massive spread of multidrug-resistant (MDR) tuberculosis in Eurasia.

Merker M Blin C Mona S Duforet-Frebourg N Lecher S Willery E Blum MG Rüsch-Gerdes S Mokrousov I Aleksic E Allix-Béguec C Antierens A Augustynowicz-Kopeć E Ballif M Barletta F Beck HP Barry CE Bonnet M Borroni E Campos-Herrero I Cirillo D Cox H Crowe S Crudu V Diel R Drobniewski F Fauville-Dufaux M Gagneux S Ghebremichael S Hanekom M Hoffner S Jiao WW Kalon S Kohl TA Kontsevaya I Lillebæk T Maeda S Nikolayevskyy V Rasmussen M Rastogi N Samper S Sanchez-Padilla E Savic B Shamputa IC Shen A Sng LH Stakenas P Toit K Varaine F Vukovic D Wahl C Warren R Supply P Niemann S Wirth T
Nature genetics 2015 Mar ; 47(3); 242-9. doi: 10.1038/ng.3195. Epub 2015 01 19

Temporal Changes in Ebola Transmission in Sierra Leone and Implications for Control Requirements: a Real-time Modelling Study.

Abstract

BACKGROUND: Between August and November 2014, the incidence of Ebola virus disease (EVD) rose dramatically in several districts of Sierra Leone.

Camacho A Kucharski A Aki-Sawyerr Y White MA Flasche S Baguelin M Pollington T Carney JR Glover R Smout E Tiffany A Edmunds WJ Funk S
PLoS currents 2015 Feb 10; 7 . doi: 10.1371/currents.outbreaks.406ae55e83ec0b5193e30856b9235ed2. Epub 2015 02 10
ebola

Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship.

Abstract

OBJECTIVES: We describe nevirapine and efavirenz exposure on and off tuberculosis treatment and consequences for virological efficacy and tolerance in patients included in the ANRS 12146/12214-CARINEMO trial.

Bhatt NB Baudin E Meggi B da Silva C Barrail-Tran A Furlan V Grinsztejn B Bonnet M Taburet AM
The Journal of antimicrobial chemotherapy 2015 Jan ; 70(1); 225-32. doi: 10.1093/jac/dku348. Epub 2014 09 18
TB/HIV coinfection drug–drug interactions efavirenz nevirapine